[Construction of hepatitis C virus-NS3 Th1 plasmid vaccine based on MHC class II-associated invariant chain peptide substitution]
Related Experiment Video
Updated: Jun 13, 2026

12:09
Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
Published on: February 28, 2019
Ming Gao1, Hai-ping Wang, Yuan Lu
1Department of Transfusion, Lanzhou General Hospital, Lanzhou Command, Lanzhou, China. 6603gaoming@163.com
Abstract
No abstract available in PubMed .

